Sericin, a silk protein derived from the cocoon of the silkworm Bombyx mori, has gained attention in recent years for its potential use in wound healing, including the treatment of abrasions. Scientific studies suggest that sericin possesses several properties beneficial for skin repair, such as biocompatibility, biodegradability, and the ability to retain moisture. Research published in peer-reviewed journals has demonstrated that sericin can promote the proliferation and migration of fibroblasts and keratinocytes, which are critical for wound closure and tissue regeneration.

Several in vitro and in vivo studies have shown that sericin accelerates re-epithelialization, reduces inflammation, and enhances collagen deposition in the wound area. Additionally, sericin's antioxidant and antimicrobial activities may contribute to a more favorable environment for wound healing by reducing oxidative stress and the risk of infection.

While most studies have been conducted in animal models or cell cultures, some early-phase clinical trials indicate positive outcomes in human subjects, such as improved healing rates and reduced scarring. However, large-scale, randomized controlled trials are still lacking, and the precise mechanisms of sericin's effects remain to be fully elucidated. Overall, the use of sericin in supporting or treating abrasions is supported by a moderate level of scientific evidence, meriting further investigation for its incorporation into clinical practice.